Filing Details
NEUROONE MEDICAL TECHNOLOGIES Corp (NASDAQ:NMTC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) Files Quarterly Report for Q0
NEUROONE MEDICAL TECHNOLOGIES Corp (NASDAQ:NMTC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
At publication ·
What changed
NEUROONE MEDICAL TECHNOLOGIES Corp (NASDAQ:NMTC) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- NEUROONE MEDICAL TECHNOLOGIES Corp filed its Q0 quarterly report (Form 10-Q) on August 13, 2026, providing unaudited financial statements and management commentary on recent business performance.
- The company's stock trades at $1.83 with a market capitalization of $29.3 million as of the filing date.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last annual report, though with less detail than the annual 10-K.
Market Context
NEUROONE MEDICAL TECHNOLOGIES Corp's stock currently trades at $1.83 with a market capitalization of $29.3M.
The 10-Q provides NEUROONE MEDICAL TECHNOLOGIES Corp's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for NEUROONE MEDICAL TECHNOLOGIES Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NMTC Stock Page
Frequently Asked Questions
Where can I read NMTC's SEC filings?
Browse all filings on our NMTC SEC filings page.
What types of SEC filings does NEUROONE MEDICAL TECHNOLOGIES Corp file?
Public companies like NEUROONE MEDICAL TECHNOLOGIES Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.